Orthopediatrics Corp (KIDS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Orthopediatrics Corp (KIDS) has a cash flow conversion efficiency ratio of -0.010x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.29 Million) by net assets ($338.71 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Orthopediatrics Corp (KIDS) defensive interval to measure how many days the company can operate on defensive assets alone.
Orthopediatrics Corp - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Orthopediatrics Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Orthopediatrics Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Orthopediatrics Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Direct Finance TA
TA:DIFI
|
0.271x |
|
Hunan Mendale Hometextile Co Ltd
SHE:002397
|
0.040x |
|
Camping World Holdings Inc
NYSE:CWH
|
0.290x |
|
Consolidated Water Co Ltd
NASDAQ:CWCO
|
0.068x |
|
Nederman Holding AB
ST:NMAN
|
-0.008x |
|
Waterdrop Inc ADR
NYSE:WDH
|
-0.010x |
|
Kforce Inc.
NYSE:KFRC
|
0.158x |
|
Immix Biopharma Inc
NASDAQ:IMMX
|
-0.116x |
Annual Cash Flow Conversion Efficiency for Orthopediatrics Corp (2014–2025)
The table below shows the annual cash flow conversion efficiency of Orthopediatrics Corp from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Orthopediatrics Corp.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $346.60 Million | $-4.85 Million | -0.014x | +81.65% |
| 2024-12-31 | $354.57 Million | $-27.05 Million | -0.076x | -6.34% |
| 2023-12-31 | $377.02 Million | $-27.05 Million | -0.072x | -24.79% |
| 2022-12-31 | $378.65 Million | $-21.77 Million | -0.057x | +0.83% |
| 2021-12-31 | $225.37 Million | $-13.06 Million | -0.058x | +26.56% |
| 2020-12-31 | $234.77 Million | $-18.53 Million | -0.079x | +36.76% |
| 2019-12-31 | $142.36 Million | $-17.77 Million | -0.125x | +34.53% |
| 2018-12-31 | $81.73 Million | $-15.58 Million | -0.191x | -25.47% |
| 2017-12-31 | $47.49 Million | $-7.22 Million | -0.152x | +18.61% |
| 2016-12-31 | $5.99 Million | $-1.12 Million | -0.187x | -136.81% |
| 2015-12-31 | $11.31 Million | $-892.00K | -0.079x | +85.72% |
| 2014-12-31 | $17.98 Million | $-9.92 Million | -0.552x | -- |
About Orthopediatrics Corp
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sp… Read more